From the Society for Maternal-Fetal Medicine, questions and answers about cfDNA for your patients.
Diet of mother’s milk vs formula has no effect on preterm infant microbiome
For preterm infants, clinical outcomes from microbial mechanisms are not affected by a diet of only human milk compared to bovine milk formulas or fortifiers.
S4E1: New RNA platform can predict pregnancy complications
In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Pregnant women with severe mental illness benefit from continued antidepressant use
There was a lower probability of initiating psycholeptics and having postpartum psychiatric emergencies in the early discontinuer and late discontinuer groups compared to the continuers.
S2E3: Providing quality care for transgender and nonbinary patients
Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.
Do cesarean-section babies still receive essential microbes?
Nearly 59% of an infant’s microbiota composition is transferred by their mother.
HemaChrome wins phase 1 of NIH Maternal Health Challenge
HemaChrom, a digital startup company measuring blood hemoglobin levels with smartphone technology, has won phase 1 of the National Institutes of Health’s RADx Tech for Maternal Health Challenge.
2 Clarke Drive Cranbury, NJ 08512